文献速递产科母胎医学

辅助生殖受孕胎儿的心脏重塑:新鲜与冻融胚胎移植的比较

Cardiac remodeling in fetuses conceived by ARTs: fresh versus frozen embryo transfer.
PubMed 文献 · Hum Reprod · 2021-01-01

这项前瞻性队列研究纳入300例单胎妊娠,比较新鲜胚胎移植、冻融胚胎移植与自然受孕胎儿的心脏结构与功能。两组辅助生殖胎儿均存在心脏重塑和亚临床功能不良,新鲜胚胎移植者改变更明显。

要点

  • 新鲜与冻融胚胎移植胎儿均出现心房增大、心室更球形及室壁增厚。
  • 新鲜胚胎移植胎儿的心脏重塑和功能不良改变较冻融胚胎移植更明显。
  • 这些超声改变属亚临床,多数指标仍在正常范围内。

核心结论

  • 新鲜和冻融胚胎移植胎儿均存在心脏重塑和亚临床功能不良,新鲜胚胎移植者改变更明显。

研究设计与样本

  • 前瞻性队列研究,2017至2020年纳入300例单胎妊娠,包括100例自然受孕、100例冻融胚胎移植和100例新鲜胚胎移植。
  • 冻融和新鲜胚胎移植妊娠均来自同一辅助生殖中心,自然受孕者按母亲年龄匹配。
  • 所有妊娠在孕28至33周行胎儿超声心动图评估心脏结构与功能。

主要发现

  • 右房/心脏面积比:新鲜胚胎移植均值18.1%(SD 3.2),冻融胚胎移植18.0%(3.9),自然受孕17.3%(3.2),线性趋势P值<0.001。
  • 右心室球形指数:新鲜胚胎移植1.62(0.29),冻融胚胎移植1.61(0.25),自然受孕1.68(0.26),P值<0.001。
  • 相对室壁厚度:新鲜胚胎移植0.79(0.21),冻融胚胎移植0.74(0.22),自然受孕0.65(0.25),P值<0.001。
  • 三尖瓣环收缩期峰值速度:新鲜胚胎移植7.17 cm/s(1.22),冻融胚胎移植7.41 cm/s(1.19),自然受孕7.58 cm/s(1.32),P值<0.001。
  • 左心室心肌性能指数:新鲜胚胎移植0.53(0.08),冻融胚胎移植0.53(0.08),自然受孕0.50(0.09),P值<0.001。

关键数值与推荐

  • 所有超声心动图比较均校正母亲年龄、未产、出生体重百分位、子痫前期和早产。

临床怎么用

  • 对辅助生殖受孕胎儿,尤其新鲜胚胎移植者,可考虑孕晚期胎儿超声心动图以早期识别心脏重塑。
  • 冻融胚胎移植胎儿心脏改变较轻,但不能据此选择移植技术,需结合整体围产结局。

局限性

  • 报告的心脏改变为亚临床,多数心血管指标在正常范围内。
  • 超声心动图改变与长期心血管疾病的关联尚未证实。
  • 冻融胚胎移植胎儿较轻的心脏特征不能作为选择该技术的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do fetuses from frozen embryo transfer (FET) present signs of cardiac remodeling and suboptimal function similar to those observed in fetuses from fresh embryo transfer (ET)? SUMMARY ANSWER: Fetuses from both fresh ET and FET present signs of fetal cardiac remodeling and suboptimal function, with more pronounced changes after fresh ET as compared to FET. WHAT IS KNOWN ALREADY: Our group and others have previously demonstrated that fetuses and children conceived by ARTs present cardiac remodeling and suboptimal function. These fetuses show dilated atria, more globular and thicker ventricles, reduced longitudinal motion, and impaired relaxation. Cardiac changes were already present in utero and persisted after birth. Most of the ART fetuses included in previous publications were from fresh ET. However, singletons from FET have different perinatal outcomes compared to those from fresh ET. There are no previous studies comparing cardiac morphology and function between fetuses following fresh and FET. STUDY DESIGN, SIZE, DURATION: This is a prospective cohort study of 300 singleton pregnancies recruited from 2017 to 2020, including 100 spontaneously conceived (SC) pregnancies, 100 fetuses conceived by IVF with FET, and 100 fetuses conceived by IVF with fresh ET. Fetal structural and functional echocardiography was performed in all pregnancies. PARTICIPANTS/MATERIALS, SETTING, METHODS: Pregnancies conceived by IVF were recruited from a single assisted reproduction center, ensuring homogeneity in IVF stimulation protocols, endometrial preparation for FET, laboratory procedures, and embryo culture conditions. SC pregnancies from fertile couples were selected from the general population and matched to IVF pregnancies by maternal age. Epidemiological and perinatal outcomes were collected in all cases. Fetal echocardiography was performed at 28-33 weeks of pregnancy to assess cardiac structure and function in all pregnancies. All echocardiographic comparisons were adjusted by maternal age, nulliparity, birthweight centile, preeclampsia, and prematurity. MAIN RESULTS AND THE ROLE OF CHANCE: Parental age, ethnicity, body mass index and smoking were similar among the study groups. Median gestational age at echocardiography and estimated fetal weight were similar in all study groups. Both fresh ET and FET groups showed similar fetal echocardiographic changes, with more pronounced features in the fresh ET as compared to FET pregnancies. Fetuses conceived by IVF showed larger atria (right atria-to-heart ratio: fresh ET mean 18.1% (SD 3.2) vs FET 18.0% (3.9) vs SC 17.3% (3.2); linear tendency P-value <0.001), more globular ventricles (right ventricular sphericity index: fresh ET 1.62 (0.29) vs FET 1.61 (0.25) vs SC 1.68 (0.26); <0.001) and thicker myocardial walls (relative wall thickness: fresh ET 0.79 (0.21) vs FET 0.74 (0.22) vs SC 0.65 (0.25); <0.001) as compared to SC pregnancies. Both fresh ET and FET groups also had signs of suboptimal systolic and diastolic function, with reduced tricuspid annular systolic peak velocity (fresh ET 7.17 cm/s (1.22) vs FET 7.41 cm/s (1.19) vs SC 7.58 cm/s (1.32); <0.001) and increased left myocardial performance index (fresh ET 0.53 (0.08) vs FET 0.53 (0.08) vs SC 0.50 (0.09); <0.001) as compared to SC pregnancies. LIMITATIONS, REASONS FOR CAUTION: The cardiac changes reported here are subclinical, with most cardiovascular indexes lying within normal ranges. Although echocardiographic changes are recognized as potential cardiovascular risk factors, their association with the long-term cardiovascular disease remains to be proven. The observed milder fetal cardiac features in FET fetuses cannot condition the choice of this technique and must be considered together with the global perinatal results related to these gestations. WIDER IMPLICATIONS OF THE FINDINGS: The identification of cardiac remodeling in fetuses conceived by IVF with fresh ET and FET represents an opportunity for early detection. Future studies are warranted to study the potential long-term consequences of these findings. STUDY FUNDING/COMPETING INTEREST(S): This project has been partially funded with support from the Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. Additionally, the research leading to these results has received funding from 'la Caixa' Foundation under grant agreement LCF/PR/GN18/10310003, the Instituto de Salud Carlos III (PI15/00130, PI17/00675, PI18/00073) integrated into the Plan Nacional de I + D+I and cofinanced by ISCIII-Subdirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER) 'Una manera de hacer Europa', Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) and AGAUR 2017 SGR grant n° 1531. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Boutet ML, Casals G, Valenzuela-Alcaraz B, et al. Cardiac remodeling in fetuses conceived by ARTs: fresh versus frozen embryo transfer. Hum Reprod. 2021. PMID: 34323946. doi:10.1093/humrep/deab159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。